It is said that Ginger Curry extract can cure muscular dystrophy

         She, the 28-year-old, from the age of 1 year old, she had a sick named progressive muscular dystrophy (PMD) which medical profession called it a “super cancer” of “muscular dystrophy”. Now she has lost all her own due to muscular atrophy and deformation more than half of the skeleton. Her name is Li Yan, a terminally ill 27 years and she want to refer “Euthanasia application” through National representatives to help her euthanasia which led to a far-reaching public discussion.

         Her action is being discussed currently. But today we are going to say another obstinate illness—spinal muscular atrophy, although these two illnesses are different in the etiopathogenesis, but the clinical manifestation is so close; the same as amyotrophy weak, eventually, they can only seat in the wheelchair, or paralyzed in the bed, even hard to speak, until death. But “I love life, but I don’t want live” Li Yan said, we can see what her deep of the painful is.

        "Yesterday, we had a stimulate news from Zhejiang NO.2 hospital: the doctor of this hospital in the USA lab, extract ASC-J9 from Ginger and Curry, he infused ASC-J9 to the SMA mouse, make effective ability to the mouse and increase in its life span. However this curcumine derivate once have been confirmed in the clinical test, it will be regard as the first drug which can really treat the muscular dystrophy. This news brings the shine to the muscular dystrophy patient.

        One case per 40000 people

        Things should be said from 2003. On Jan 2003, professor Yang Zhi Ming who is be recommended professor Chen Zhaoming, regard as join training Dr. to the medicine centre of the university of Rochester discussing, American instructor is a famous international male hormone receptor, professor Zhang Chuanxiang.

        Dr. Yang said, SBMA is also named Kennedy’s disease, one case per 40000 people, mainly occur between age 30-50 years. Since it is relative with male hormone receptor’s Variable-length amino acid, so the patients are mostly male. They are appeared amyotrophy in the early time, the appearance is the two lower limb muscle weakness, at the end they only can sit in the wheelchair, cannot move, shaking head, and hard to talk, treatment is hopeful less.

        Drug is extract from ginger and curry

        In the American lab, Dr. Yang has been discuss 60 amyotrophic mice for 3 years, the mixture ASC-J9 which is extract from ginger and curry, injected into the amyotrophic mouse. Result shows that the mouse which has lower limb muscle weakness and cannot stand on the wood, even resumption the capability of activity. They almost have no difference with the normal ones.

        Not only these, Dr. Yang explained because of the SMBA is relative with male hormone receptor, and the patient have to used operation or drug to Emasculation in Adolescent.        

        ASC-J9 treated obstinate illness hopeful

        On July 2005, Dr. Yang Zhiming completed research then come back homeland, in this period of time, he has completed 3 papers as the first author, 6 papers as the combined. On Mar 6, 2007, his first papers as the first author, named <Curcumine derivatives ASC-J9 through lower androgen rector to treat SMAB>, released on the world famous magazine <Natural Medicine>.

        Magazine “Nature” series is the world’s most prestigious journals in the scientific area. Since its inauguration in 1869, many researchers in the field have made an important outcome of the authoritative academic journal. Since it was been found from 1869, it release many field’s important academic achievements. Many major scientific and the most influential scientific discovery, including Dolly, all inform the world by <natural> magazine.

        In the “natural medicine” magazine published papers, it will certainly be a great sense of originality and has a great impetus on medicine. At present, Yang Zhiming is the first person, who published paper in the first author of the magazine in Zhejiang medical profession.

        It is also expected that once clinical trials confirm efficacy. ASC-J9 can be expected to become the world's first truly drug for the treatment of muscular dystrophy.

back